Barclays PLC has disclosed its position in HIPGNOSIS SONGS FUND LTD, revealing ownership and control of relevant securities representing 2.47% and short positions of 2.45%. The disclosure includes the purchase and sale of ordinary securities, as well as cash-settled derivative transactions. Barclays PLC's dealings on July 11, 2024, involved the purchase of 29,839,041 ordinary securities and cash-settled derivatives, along with sales of 29,585,744 ordinary securities. The purchases were made at various prices per unit, while the sales were executed at prices ranging from 1.0050 GBP to 1.0160 GBP per unit.

The disclosure also details cash-settled derivative transactions, including decreasing and increasing short positions through CFDs and SWAPs. Additionally, it outlines stock-settled derivative transactions, but no other dealings, such as subscribing for new securities, were reported. The disclosure indicates that there are no indemnity or other dealings arrangements, agreements, arrangements, or understandings relating to options or derivatives. Furthermore, no supplemental Form 8 (Open Positions) is attached to the disclosure.

Barclays PLC's disclosure provides a comprehensive overview of its interests, short positions, and dealings in HIPGNOSIS SONGS FUND LTD's relevant securities, offering transparency regarding its recent activities in relation to the company's securities.